Novel adenosine a3 receptor modulators

C - Chemistry – Metallurgy – 07 – D

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07D 473/06 (2006.01) A61K 31/522 (2006.01) A61P 35/00 (2006.01)

Patent

CA 2596612

A class of novel antagonists for the adenosine A3 receptor are disclosed. These compounds are useful as therapeutic agents for a number of diseases and medical conditions that are mediated by the A3 receptor. The compounds of this invention are also useful as diagnostic agents for the A3 receptor.

La présente invention concerne une classe de nouveaux antagonistes du récepteur A3 d'adénosine. Ces composés conviennent comme agents thérapeutiques pour un certain nombre de maladies et de pathologie médicale induite par le récepteur A3. Le composé de sept inventions convienne aussi comme agents de diagnostic du récepteur A3.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Novel adenosine a3 receptor modulators does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Novel adenosine a3 receptor modulators, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Novel adenosine a3 receptor modulators will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1401109

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.